Trade Summary

5 days ago, Smith Julie, serving as Dir at Exelixis, Inc. (EXEL), sold 106,539 shares at $44.00 per share, for a total transaction value of $4,687,346.00. Following this transaction, Smith Julie now holds 20,590 shares of EXEL.

This sale represents a 84.00% decrease in Smith Julie's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, February 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 19, 2026, 2 days after the trade was made.

Exelixis, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.